ATE72245T1 - Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure. - Google Patents

Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure.

Info

Publication number
ATE72245T1
ATE72245T1 AT86307045T AT86307045T ATE72245T1 AT E72245 T1 ATE72245 T1 AT E72245T1 AT 86307045 T AT86307045 T AT 86307045T AT 86307045 T AT86307045 T AT 86307045T AT E72245 T1 ATE72245 T1 AT E72245T1
Authority
AT
Austria
Prior art keywords
diabicycloalkylquinolone
carbon acid
carbon
substituted bridge
alkyl
Prior art date
Application number
AT86307045T
Other languages
German (de)
English (en)
Inventor
Martin Raymond Jefson
Paul Robert Mcguirk
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE72245T1 publication Critical patent/ATE72245T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT86307045T 1985-09-18 1986-09-12 Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure. ATE72245T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77747185A 1985-09-18 1985-09-18
EP86307045A EP0215650B1 (en) 1985-09-18 1986-09-12 Substituted bridged-diazabicycloalkyl quinolone carboxylic acids

Publications (1)

Publication Number Publication Date
ATE72245T1 true ATE72245T1 (de) 1992-02-15

Family

ID=25110350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86307045T ATE72245T1 (de) 1985-09-18 1986-09-12 Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure.

Country Status (42)

Country Link
US (3) US4861779A (instruction)
EP (1) EP0215650B1 (instruction)
JP (1) JPH0798819B2 (instruction)
KR (1) KR870000961B1 (instruction)
CN (1) CN1014789B (instruction)
AT (1) ATE72245T1 (instruction)
AU (1) AU576302B2 (instruction)
BG (2) BG49275A3 (instruction)
CA (1) CA1340734C (instruction)
CY (1) CY1774A (instruction)
CZ (1) CZ277825B6 (instruction)
DD (1) DD259190A5 (instruction)
DE (2) DE3683711D1 (instruction)
DK (1) DK171276B1 (instruction)
EG (1) EG18184A (instruction)
ES (1) ES2001428A6 (instruction)
FI (1) FI87565C (instruction)
GR (1) GR862363B (instruction)
HK (1) HK132795A (instruction)
HU (1) HU200462B (instruction)
IE (1) IE58966B1 (instruction)
IL (1) IL80033A (instruction)
IN (1) IN166416B (instruction)
LU (1) LU90356I2 (instruction)
MA (1) MA20770A1 (instruction)
MW (1) MW5886A1 (instruction)
MX (1) MX173358B (instruction)
MY (1) MY102518A (instruction)
NO (1) NO170335C (instruction)
NZ (1) NZ217614A (instruction)
OA (1) OA08410A (instruction)
PH (2) PH24048A (instruction)
PL (1) PL149987B1 (instruction)
PT (1) PT83388B (instruction)
SG (1) SG28094G (instruction)
SK (1) SK278605B6 (instruction)
SU (1) SU1482531A3 (instruction)
UA (1) UA6340A1 (instruction)
YU (1) YU45024B (instruction)
ZA (1) ZA867063B (instruction)
ZM (1) ZM8586A1 (instruction)
ZW (1) ZW19386A1 (instruction)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (instruction) * 1985-09-18 1990-05-05 Pfizer
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
EP0251308B1 (de) * 1986-07-04 1990-11-22 Chemie Linz Gesellschaft m.b.H. 4-Chinolon-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4965273A (en) * 1986-10-08 1990-10-23 Bristol-Myers Company Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
US4933335A (en) * 1987-08-07 1990-06-12 Warner-Lambert Company Quinolones as antibacterial agents
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
WO1990002123A1 (en) * 1988-08-23 1990-03-08 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
US5147873A (en) * 1988-08-23 1992-09-15 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
US4895943A (en) * 1988-10-25 1990-01-23 Pfizer Inc. Preparation of 1,4-diazabicyclo(3.2.2)nonane
US5036153A (en) * 1989-05-11 1991-07-30 Braish Tamim F Preparation of 2,5-diazabicyclo[2.2.1]heptanes and intermediates
US5214051A (en) * 1989-08-01 1993-05-25 Pfizer Inc. Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed
US5013839A (en) * 1989-09-25 1991-05-07 Pfizer Inc. Process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1) heptanes
US5095121A (en) * 1989-09-25 1992-03-10 Pfizer Inc Process for optically active 2-alkyl-2,5-diazabicyclo(2.2.1)heptanes
US5157125A (en) * 1989-09-25 1992-10-20 Pfizer Inc. Optically active 2-alkyl-2,5-diazabicyclo[2.2.1]heptanes
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
DE69200921T2 (de) * 1991-03-01 1995-05-04 Pfizer 1-azabicyclo[3.2.2]nonan-3-aminderivate.
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
GB2291421A (en) * 1994-07-16 1996-01-24 Pfizer A process for preparing a quinoline carboxylic acid
ES2092963B1 (es) * 1995-04-12 1997-12-16 Sint Quimica Sa Procedimiento para la preparacion del acido 1-ciclopropil-6-fluoro-1, 4-dihidro-7-(1s,4s)-5-metil-2,5-diazabiciclo(2.2.1) hept-2-il)-4-oxo-3-quinolincarboxilico y sus sales.
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
US6056436A (en) * 1997-02-20 2000-05-02 University Of Maryland Simultaneous measurement of temperature and strain using optical sensors
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
AU774867B2 (en) 1999-05-04 2004-07-08 Neurosearch A/S Heteroaryl diazabicycloalkanes, their preparation and use
FR2809731B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2809730B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
FR2809732B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
WO2002070522A1 (en) * 2001-03-02 2002-09-12 Neurosearch A/S Novel 2,5-diazabicyclo[2.2.1]heptane derivatives
WO2004024729A1 (en) * 2002-09-10 2004-03-25 Pfizer Products Inc. Diazabicyclic compounds useful in the treatment of cns and other disorders
KR101129933B1 (ko) * 2002-09-25 2012-03-23 메모리 파마슈티칼스 코포레이션 인다졸, 벤조티아졸 및 벤조이소티아졸 및 그의 제조 및용도
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
RS20060391A (en) * 2003-12-22 2008-11-28 Memory Pharmaceuticals Corporation, Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof
NZ550534A (en) * 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
EP1742944B1 (en) * 2004-04-22 2010-11-10 Memory Pharmaceuticals Corporation Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
EP1745046B1 (en) * 2004-05-07 2011-04-13 Memory Pharmaceuticals Corporation 1 h-indazoles, benzothiazoles, 1,2-benziosoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
MX2007007328A (es) 2004-12-22 2007-07-25 Memory Pharm Corp Ligandos del receptor alfa-7 nicotinico y preparacion y sus usos.
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
CA2641678A1 (en) * 2006-02-10 2007-08-16 Neurosearch A/S 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
AU2007213670A1 (en) 2006-02-10 2007-08-16 Neurosearch A/S 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2009526024A (ja) 2006-02-10 2009-07-16 ノイロサーチ アクティーゼルスカブ ニコチン性アセチルコリン受容体アゴニストとしての3−ヘテロアリール−3,9−ジアザビシクロ[3.3.1]ノナン誘導体
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2009111680A1 (en) * 2008-03-07 2009-09-11 Smithline Beecham Corporation Trpv4 antagonists
CN102421784B (zh) * 2009-03-11 2015-09-30 杏林制药株式会社 作为gsk-3抑制剂的7-环烷基氨基喹诺酮
AU2011315555B2 (en) 2010-10-12 2016-03-10 Elanco Animal Health Gmbh Non-starch based soft chewables
MX375182B (es) 2012-12-19 2025-03-06 Elanco Animal Health Gmbh Comprimidos que tienen aceptacion mejorada y buena stabilidad durante el almacenamiento.
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
EP4025220A4 (en) * 2019-09-06 2023-10-04 Elanco US Inc. TASTY VETERINARY MEDICINAL COMPOSITIONS IN GRANULE FORM
CN115368369A (zh) * 2022-08-16 2022-11-22 浙江国邦药业有限公司 一种甲磺酸达氟沙星脱甲基杂质的合成方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
JPS54112876A (en) * 1978-02-20 1979-09-04 Sumitomo Chem Co Ltd Preparation of 1-substituted-1,4-dihydro-4-oxo-3-quinoline carboxylic acid derivatives
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS5823381A (ja) * 1981-08-05 1983-02-12 Nec Corp 磁気バブル検出装置
JPS5823382A (ja) * 1981-08-05 1983-02-12 Nec Corp コンテイギユアス・デイスク・バブル検出・消去器
JPS58204193A (ja) * 1982-01-14 1983-11-28 Kobe Steel Ltd 表面処理鋼板
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
JPS58204194A (ja) * 1982-05-21 1983-11-28 Hitachi Ltd 電気ニツケルメツキ方法
JPS58219293A (ja) * 1982-06-15 1983-12-20 Chiyoda Chem Eng & Constr Co Ltd 重質油の水素化分解方法
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
JPS59137481A (ja) * 1983-01-26 1984-08-07 Hokuriku Seiyaku Co Ltd 7−ジアザビシクロアルカン置換−4−オキソ−1,4−ジヒドロキノリン−3−カルボン酸誘導体
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
JPS6212760A (ja) * 1984-12-14 1987-01-21 Dai Ichi Seiyaku Co Ltd 1−(2−ハロゲノシクロプロピル)キノリンカルボン酸誘導体
IL77846A (en) * 1985-03-25 1989-08-15 Warner Lambert Co Process for the preparation of 7-amino-quinolin-4-oxy-3-carboxylic acid derivatives
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4684648A (en) * 1985-05-10 1987-08-04 Otsuka Pharmaceutical Company Limited Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof
IN166416B (instruction) * 1985-09-18 1990-05-05 Pfizer
US4772706A (en) * 1986-01-13 1988-09-20 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4840956A (en) * 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
EP0251308B1 (de) * 1986-07-04 1990-11-22 Chemie Linz Gesellschaft m.b.H. 4-Chinolon-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE3721745A1 (de) * 1986-07-04 1988-01-14 Lentia Gmbh Bicyclisch substituierte chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3641312A1 (de) * 1986-12-03 1988-06-09 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
FI87565C (fi) 1993-01-25
LU90356I2 (fr) 1999-04-26
ZM8586A1 (en) 1987-03-27
NO863718D0 (no) 1986-09-17
YU161786A (en) 1987-10-31
PH24048A (en) 1990-03-05
NZ217614A (en) 1989-11-28
EG18184A (en) 1992-12-30
JPH0798819B2 (ja) 1995-10-25
BG49275A3 (en) 1991-09-16
US4861779A (en) 1989-08-29
IL80033A0 (en) 1986-12-31
EP0215650B1 (en) 1992-01-29
CZ277825B6 (en) 1993-06-16
PT83388A (en) 1986-10-01
KR870003106A (ko) 1987-04-15
FI863756A0 (fi) 1986-09-17
HUT43070A (en) 1987-09-28
MX173358B (es) 1994-02-23
EP0215650A2 (en) 1987-03-25
ZW19386A1 (en) 1986-12-10
SG28094G (en) 1994-10-28
AU6276886A (en) 1987-03-19
BG61091B2 (bg) 1996-10-31
OA08410A (fr) 1988-06-30
YU45024B (en) 1991-06-30
SK667886A3 (en) 1997-11-05
IE58966B1 (en) 1993-12-01
DK445886D0 (da) 1986-09-17
HU200462B (en) 1990-06-28
CA1340734C (en) 1999-09-14
PL149987B1 (en) 1990-04-30
EP0215650A3 (en) 1987-12-02
CY1774A (en) 1995-10-20
SU1482531A3 (ru) 1989-05-23
PT83388B (pt) 1989-05-12
PL261410A1 (en) 1987-11-16
CZ667886A3 (en) 1993-02-17
NO170335B (no) 1992-06-29
IN166416B (instruction) 1990-05-05
KR870000961B1 (ko) 1987-05-14
IE862479L (en) 1987-03-18
CN86106385A (zh) 1987-06-03
US5091383A (en) 1992-02-25
MW5886A1 (en) 1987-12-09
NO863718L (no) 1987-03-19
FI863756L (fi) 1987-03-19
DE3683711D1 (de) 1992-03-12
MX3751A (es) 1993-09-01
DK445886A (da) 1987-05-27
MA20770A1 (fr) 1987-04-01
IL80033A (en) 1992-05-25
JPS62103083A (ja) 1987-05-13
MY102518A (en) 1992-07-31
SK278605B6 (en) 1997-11-05
US4775668A (en) 1988-10-04
FI87565B (fi) 1992-10-15
AU576302B2 (en) 1988-08-18
NO170335C (no) 1992-10-07
DE19675019I2 (de) 2004-01-29
UA6340A1 (uk) 1994-12-29
DD259190A5 (de) 1988-08-17
ZA867063B (en) 1988-04-27
CN1014789B (zh) 1991-11-20
DK171276B1 (da) 1996-08-19
GR862363B (en) 1987-01-19
PH25338A (en) 1991-04-30
HK132795A (en) 1995-09-01
ES2001428A6 (es) 1988-05-16

Similar Documents

Publication Publication Date Title
ATE72245T1 (de) Substituierte verbrueckte diabicycloalkylchinoloncarbonsaeure.
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
DE3876712D1 (de) Antianaerobe naphthyridinverbindungen.
ATE84028T1 (de) Biologisch aktive verbindungen.
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.